These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 12585654

  • 1. Magnetic resonance imaging of breast cancer angiogenesis: a review.
    Furman-Haran E, Kelcz F, Degani H.
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):47-54. PubMed ID: 12585654
    [Abstract] [Full Text] [Related]

  • 2. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ, Pallavicini MG, Fleming LM, Gibbs J, Wang D, Li KL, Partridge SC, Henry RG, Shalinsky DR, Hu-Lowe D, Park JW, McShane TM, Lu Y, Brasch RC, Hylton NM.
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [Abstract] [Full Text] [Related]

  • 3. Magnetic resonance of the breast: correlation between enhancement patterns and microvessel density in malignant tumors.
    Carriero A, Ambrossini R, Mattei PA, Angelucci D, Bonomo L.
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):83-7. PubMed ID: 12585660
    [Abstract] [Full Text] [Related]

  • 4. Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights.
    Turetschek K, Preda A, Novikov V, Brasch RC, Weinmann HJ, Wunderbaldinger P, Roberts TP.
    J Magn Reson Imaging; 2004 Jul; 20(1):138-44. PubMed ID: 15221819
    [Abstract] [Full Text] [Related]

  • 5. [Fast MRI contrast medium dynamics for characterization of tumors. Experiences with functional MR-mammography].
    Knopp MV, Hoffmann U, Brix G, Hawighorst H, Junkermann HJ, van Kaick G.
    Radiologe; 1995 Dec; 35(12):964-72. PubMed ID: 8584640
    [Abstract] [Full Text] [Related]

  • 6. Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging.
    Hylton NM.
    Magn Reson Imaging Clin N Am; 2001 May; 9(2):321-32, vi. PubMed ID: 11493422
    [Abstract] [Full Text] [Related]

  • 7. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment.
    Cuenod CA, Fournier L, Balvay D, Guinebretière JM.
    Abdom Imaging; 2006 May; 31(2):188-93. PubMed ID: 16447089
    [Abstract] [Full Text] [Related]

  • 8. High-resolution three-dimensional MR angiography of rodent tumors: morphologic characterization of intratumoral vasculature.
    Fink C, Kiessling F, Bock M, Lichy MP, Misselwitz B, Peschke P, Fusenig NE, Grobholz R, Delorme S.
    J Magn Reson Imaging; 2003 Jul; 18(1):59-65. PubMed ID: 12815640
    [Abstract] [Full Text] [Related]

  • 9. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer.
    Su MY, Cheung YC, Fruehauf JP, Yu H, Nalcioglu O, Mechetner E, Kyshtoobayeva A, Chen SC, Hsueh S, McLaren CE, Wan YL.
    J Magn Reson Imaging; 2003 Oct; 18(4):467-77. PubMed ID: 14508784
    [Abstract] [Full Text] [Related]

  • 10. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
    Chou CP, Wu MT, Chang HT, Lo YS, Pan HB, Degani H, Furman-Haran E.
    Acad Radiol; 2007 May; 14(5):561-73. PubMed ID: 17434070
    [Abstract] [Full Text] [Related]

  • 11. Parametric imaging of tumor perfusion with deuterium magnetic resonance imaging.
    Bogin L, Margalit R, Ristau H, Mispelter J, Degani H.
    Microvasc Res; 2002 Jul; 64(1):104-15. PubMed ID: 12074636
    [Abstract] [Full Text] [Related]

  • 12. Magnetic resonance imaging of tumor vasculature.
    Degani H, Chetrit-Dadiani M, Bogin L, Furman-Haran E.
    Thromb Haemost; 2003 Jan; 89(1):25-33. PubMed ID: 12540950
    [Abstract] [Full Text] [Related]

  • 13. Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation.
    Daldrup-Link HE, Okuhata Y, Wolfe A, Srivastav S, Øie S, Ferrara N, Cohen RL, Shames DM, Brasch RC.
    Microcirculation; 2004 Jan; 11(5):387-96. PubMed ID: 15280064
    [Abstract] [Full Text] [Related]

  • 14. Imaging tumor angiogenesis: functional assessment using MDCT or MRI?
    Goh V, Padhani AR.
    Abdom Imaging; 2006 Jan; 31(2):194-9. PubMed ID: 16333695
    [Abstract] [Full Text] [Related]

  • 15. Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis.
    Atkin G, Taylor NJ, Daley FM, Stirling JJ, Richman P, Glynne-Jones R, d'Arcy JA, Collins DJ, Padhani AR.
    Br J Surg; 2006 Aug; 93(8):992-1000. PubMed ID: 16673354
    [Abstract] [Full Text] [Related]

  • 16. Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data.
    Makkat S, Luypaert R, Sourbron S, Stadnik T, De Mey J.
    J Magn Reson Imaging; 2007 Jun; 25(6):1159-67. PubMed ID: 17520720
    [Abstract] [Full Text] [Related]

  • 17. Dynamic contrast enhanced MRI in prostate cancer.
    Alonzi R, Padhani AR, Allen C.
    Eur J Radiol; 2007 Sep; 63(3):335-50. PubMed ID: 17689907
    [Abstract] [Full Text] [Related]

  • 18. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
    Rosen MA, Schnall MD.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
    [Abstract] [Full Text] [Related]

  • 19. Recent advances in breast MRI and MRS.
    Sinha S, Sinha U.
    NMR Biomed; 2009 Jan 15; 22(1):3-16. PubMed ID: 18654998
    [Abstract] [Full Text] [Related]

  • 20. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.
    Choyke PL, Dwyer AJ, Knopp MV.
    J Magn Reson Imaging; 2003 May 15; 17(5):509-20. PubMed ID: 12720260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.